Topical vitamin A shows promiseTopical vitamin A treatment of recalcitrant common warts.
We explored the use of topical vitamin A in treating stubborn common warts. In a case study, a healthy 30-year-old woman with a long history of persistent warts tried multiple treatments without success.
After applying natural vitamin A from fish liver oil daily, most warts cleared up in about 70 days, while a larger wart took up to six months to resolve.
While this case suggests potential benefits, further controlled studies are needed to better understand vitamin A’s effectiveness against common warts and other related skin issues.
Read More
Topical Tretinoin enhances wart treatmentThe efficacy and safety of topical Tretinoin combined with superficial X-ray therapy (SXRT) in treating periungual warts.
We explored the combined effect of topical Tretinoin, a vitamin A derivative, with Superficial X-ray therapy (SXRT) in treating periungual warts (PWs). In this study, we observed 65 PWs, divided into two groups. One group received only SXRT, while the other group received SXRT along with Tretinoin cream from the very beginning.
Our findings indicated that the combination treatment with Tretinoin significantly enhanced the clearance rate of the warts compared to SXRT alone. Specifically, 92.7% of the PWs in the combined treatment group cleared completely within the study period, compared to just 75% in the SXRT group. Additionally, the time it took for the warts to heal was shorter with the combined treatment—16 days compared to 19.9 days for SXRT alone.
We also found that there were no severe side effects, and the minor effects reported were manageable. This suggests that using topical Tretinoin with SXRT is not only effective but also safe, making it an appealing option for those seeking a non-invasive treatment for PWs.
Read More
Vitamin A shows limited wart benefitsEffect of oral aromatic retinoid (Ro 10-9359) on human papilloma virus-2-induced common warts.
We explored the impact of the oral aromatic retinoid, Ro 10-9359, on common warts caused by human papilloma virus (HPV) 2 in a patient with chronic lymphatic leukemia.
The treatment led to rapid improvement, with no detectable viral particles or DNA during the therapy. However, the treatment had to stop due to the patient's development of a liposarcoma, leading to a relapse of the warts.
Notably, the same HPV-2 subtype was present before and after the treatment, suggesting limited long-term effectiveness.
Read More
RBP links to wart resistanceMeasuring the serum level of retinol-binding protein can enhance the treatment of recalcitrant warts.
We conducted a case-control study to investigate the link between retinol-binding protein (RBP) levels and resistant warts, which are warts that don’t respond to conventional treatments. Our research included 30 patients with such warts and 30 matched healthy controls, allowing us to measure serum levels of RBP through a method called ELISA.
From our findings, we observed a significant difference in serum RBP levels between the two groups, suggesting a connection between low RBP and the development of stubborn warts. RBP plays a crucial role in the metabolism of vitamin A, and a deficiency may hinder the body’s ability to fight off the viral factors involved in wart formation.
Despite the results indicating low serum RBP levels in patients with resistant warts, the study did not establish a direct treatment effect of vitamin A on warts. While low RBP levels might highlight a possible pathway in wart persistence, further research is needed to confirm if increasing vitamin A could effectively treat these stubborn skin issues.
Read More
Mixed outcomes for wart treatment[First experience with retinoid acid derivative Ro 10-9359 in the treatment of viral epithelioma].
We explored the effectiveness of a retinoic acid derivative, Ro 10-9359, for treating warts, particularly in patients who struggled to walk due to extensive verrucae plantares. While two patients experienced significant recovery, a larger group of 12 with verrucae vulgares showed disappointing results. We gradually increased the dosage to over 1.5 mg/kg, monitoring for side effects, which were notable but manageable. Overall, Ro 10-9359 may be beneficial for stubborn plantar warts, especially when standard treatments fail, but the results vary significantly among patients.
Read More